172 related articles for article (PubMed ID: 19493677)
1. Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants.
Di Cecco L; Melissari E; Mariotti V; Iofrida C; Galli A; Guidugli L; Lombardi G; Caligo MA; Iacopetti P; Pellegrini S
Eur J Cancer; 2009 Aug; 45(12):2187-96. PubMed ID: 19493677
[TBL] [Abstract][Full Text] [Related]
2. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance.
Caligo MA; Bonatti F; Guidugli L; Aretini P; Galli A
Hum Mutat; 2009 Jan; 30(1):123-33. PubMed ID: 18680205
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
4. A recombination-based method to characterize human BRCA1 missense variants.
Guidugli L; Rugani C; Lombardi G; Aretini P; Galli A; Caligo MA
Breast Cancer Res Treat; 2011 Jan; 125(1):265-72. PubMed ID: 20737206
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
6. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.
Ostrow KL; McGuire V; Whittemore AS; DiCioccio RA
Cancer Genet Cytogenet; 2004 Sep; 153(2):177-80. PubMed ID: 15350310
[TBL] [Abstract][Full Text] [Related]
7. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.
Lodovichi S; Vitello M; Cervelli T; Galli A
Cell Cycle; 2016 Oct; 15(20):2723-31. PubMed ID: 27484786
[TBL] [Abstract][Full Text] [Related]
10. Missense mutations in the BRCT domain of BRCA-1 from high-risk women frequently perturb strongly hydrophobic amino acids conserved among mammals.
Figge MA; Blankenship L
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1037-41. PubMed ID: 15184261
[TBL] [Abstract][Full Text] [Related]
11. [Studies of mutations in BRCA1 transactivation domain by visualization of chromatin structure].
Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
Yi Chuan Xue Bao; 2002; 29(11):941-8. PubMed ID: 12645254
[TBL] [Abstract][Full Text] [Related]
12. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model.
Yang Y; Swaminathan S; Martin BK; Sharan SK
Hum Mol Genet; 2003 Sep; 12(17):2121-31. PubMed ID: 12915465
[TBL] [Abstract][Full Text] [Related]
13. Effect of BRCA1 missense variants on gene reversion in DNA double-strand break repair mutants and cell cycle-arrested cells of Saccharomyces cerevisiae.
Lodovichi S; Bellè F; Cervelli T; Lorenzoni A; Maresca L; Cozzani C; Caligo MA; Galli A
Mutagenesis; 2020 Mar; 35(2):189-195. PubMed ID: 31769492
[TBL] [Abstract][Full Text] [Related]
14. Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast.
Millot GA; Berger A; Lejour V; Boulé JB; Bobo C; Cullin C; Lopes J; Stoppa-Lyonnet D; Nicolas A
Hum Mutat; 2011 Dec; 32(12):1470-80. PubMed ID: 21922593
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 is differentially expressed in human tumor cells.
Meng QH; Yuan RQ; Goldberg ID; Rosen EM; Fan SJ
Shi Yan Sheng Wu Xue Bao; 2001 Mar; 34(1):55-64. PubMed ID: 12549011
[TBL] [Abstract][Full Text] [Related]
16. Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study.
Iofrida C; Melissari E; Mariotti V; Guglielmi C; Guidugli L; Caligo MA; Pellegrini S
BMC Cancer; 2012 May; 12():207. PubMed ID: 22646717
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.
Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND
Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400
[TBL] [Abstract][Full Text] [Related]
18. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
Gough CA; Gojobori T; Imanishi T
Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a carboxy-terminal BRCA1 interacting protein.
Wong AK; Ormonde PA; Pero R; Chen Y; Lian L; Salada G; Berry S; Lawrence Q; Dayananth P; Ha P; Tavtigian SV; Teng DH; Bartel PL
Oncogene; 1998 Nov; 17(18):2279-85. PubMed ID: 9811458
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of point mutations in BRCA1 gene using hybridization on hydrogel microchips].
Fedorova OE; Sinitska ON; Tikhomirova LP; Vishnevskaia IaV; Zasedatelev AS; Nasedkina TV
Mol Biol (Mosk); 2006; 40(1):31-6. PubMed ID: 16523689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
